Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: PALOMA, an open-label, multicenter, dose escalation phase 1b study.

Matthew Krebs; Melissa Johnson; Byoung Cho; Kyung-Soon Park; Nahor Haddish; Donna Zemlickis; Anna Mitselos; Francis Meacle; Roland Knoblauch; Peter Hellemans; Anna Minchom

doi:10.1200/JCO.2021.39.15_suppl.TPS3150

Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: PALOMA, an open-label, multicenter, dose escalation phase 1b study.

Matthew Krebs, Melissa Johnson, Byoung Cho, Kyung-Soon Park, Nahor Haddish, Donna Zemlickis, Anna Mitselos, Francis Meacle, Roland Knoblauch, Peter Hellemans, Anna Minchom

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	TPS3150-TPS3150
Journal	Journal of Clinical Oncology
Volume	39
DOIs	https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS3150
Publication status	Published - 20 May 2021

Access to Document

10.1200/JCO.2021.39.15_suppl.TPS3150

Cite this

Krebs, M., Johnson, M., Cho, B., Park, K.-S., Haddish, N., Zemlickis, D., Mitselos, A., Meacle, F., Knoblauch, R., Hellemans, P., & Minchom, A. (2021). Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: PALOMA, an open-label, multicenter, dose escalation phase 1b study. Journal of Clinical Oncology, 39, TPS3150-TPS3150. https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS3150

@article{812d3cb2cf374a7788fe23439db6ddd7,

title = "Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: PALOMA, an open-label, multicenter, dose escalation phase 1b study.",

author = "Matthew Krebs and Melissa Johnson and Byoung Cho and Kyung-Soon Park and Nahor Haddish and Donna Zemlickis and Anna Mitselos and Francis Meacle and Roland Knoblauch and Peter Hellemans and Anna Minchom",

year = "2021",

month = may,

day = "20",

doi = "10.1200/JCO.2021.39.15_suppl.TPS3150",

language = "English",

volume = "39",

pages = "TPS3150--TPS3150",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

}

Krebs, M, Johnson, M, Cho, B, Park, K-S, Haddish, N, Zemlickis, D, Mitselos, A, Meacle, F, Knoblauch, R, Hellemans, P & Minchom, A 2021, 'Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: PALOMA, an open-label, multicenter, dose escalation phase 1b study.', Journal of Clinical Oncology, vol. 39, pp. TPS3150-TPS3150. https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS3150

TY - JOUR

T1 - Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: PALOMA, an open-label, multicenter, dose escalation phase 1b study.

AU - Krebs, Matthew

AU - Johnson, Melissa

AU - Cho, Byoung

AU - Park, Kyung-Soon

AU - Haddish, Nahor

AU - Zemlickis, Donna

AU - Mitselos, Anna

AU - Meacle, Francis

AU - Knoblauch, Roland

AU - Hellemans, Peter

AU - Minchom, Anna

PY - 2021/5/20

Y1 - 2021/5/20

U2 - 10.1200/JCO.2021.39.15_suppl.TPS3150

DO - 10.1200/JCO.2021.39.15_suppl.TPS3150

M3 - Meeting Abstract

SN - 0732-183X

VL - 39

SP - TPS3150-TPS3150

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -